|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.915 USD | +1.13% |
|
-2.48% | +29.00% |
| Capitalization | 505M 431M 398M 375M 697M 47.27B 715M 4.66B 1.83B 22.58B 1.89B 1.85B 80.65B | P/E ratio 2026 * |
-2.48x | P/E ratio 2027 * | -3.08x |
|---|---|---|---|---|---|
| Enterprise value | 341M 292M 269M 254M 472M 31.97B 484M 3.15B 1.24B 15.27B 1.28B 1.25B 54.55B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 5.34x |
| Free-Float |
98.55% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Larimar Therapeutics, Inc.
| 1 day | +1.13% | ||
| 1 week | -2.48% | ||
| Current month | +9.22% | ||
| 1 month | +11.70% | ||
| 3 months | +44.13% | ||
| 6 months | +26.03% | ||
| Current year | +29.00% |
| 1 week | 4.69 |  | 5.35 |
| 1 month | 4.2 | | 5.35 |
| Current year | 2.72 | | 6.42 |
| 1 year | 1.73 | | 6.42 |
| 3 years | 1.61 | | 13.68 |
| 5 years | 1.53 | | 15.49 |
| 10 years | 1.53 | | 25.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 2020-04-30 | |
Michael Celano
DFI | Director of Finance/CFO | 67 | 2020-05-27 |
Noreen Scherer
CTO | Chief Tech/Sci/R&D Officer | - | 2018-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 67 | 2019-12-31 | |
Joseph Truitt
CHM | Chairman | 61 | 2020-05-27 |
Thomas Hamilton
BRD | Director/Board Member | 58 | 2020-05-27 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -5.16% | 0% | 293,477 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.13% | -2.48% | +162.83% | +8.50% | 505M | |
| +4.14% | +8.70% | +33.67% | +102.99% | 49.28B | |
| +0.79% | +6.56% | +104.51% | +23.64% | 46.64B | |
| +0.54% | -6.85% | +113.86% | +806.90% | 32.62B | |
| +2.72% | +11.07% | -2.65% | -23.16% | 24.45B | |
| +5.50% | +6.40% | +86.66% | -30.88% | 18.64B | |
| +2.65% | +5.22% | +44.66% | -34.58% | 17.27B | |
| +0.07% | -1.85% | +67.76% | +195.92% | 16.21B | |
| +3.32% | +8.01% | -20.55% | +1,222.29% | 15.53B | |
| -0.41% | -3.63% | +60.66% | - | 14.5B | |
| Average | +2.04% | +0.67% | +65.14% | +252.40% | 23.57B | |
| Weighted average by Cap. | +2.20% | +1.40% | +60.73% | +239.32% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 62.61M 53.49M 49.32M 46.54M 86.49M 5.86B 88.69M 578M 227M 2.8B 235M 230M 10B |
| Net income | -199M -170M -157M -148M -275M -18.65B -282M -1.84B -722M -8.91B -747M -732M -31.81B | -176M -150M -139M -131M -243M -16.47B -249M -1.62B -638M -7.87B -660M -646M -28.1B |
| Net Debt | -163M -140M -129M -121M -226M -15.3B -231M -1.51B -593M -7.31B -613M -600M -26.1B | -171M -146M -135M -127M -236M -15.99B -242M -1.58B -620M -7.64B -641M -627M -27.28B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-04-14 | 4.915 $ | +1.13% | 406,242 |
| 26-04-13 | 4.860 $ | +0.21% | 1,438,914 |
| 26-04-10 | 4.850 $ | -4.72% | 1,898,866 |
| 26-04-09 | 5.090 $ | 0.00% | 1,401,885 |
| 26-04-08 | 5.090 $ | +0.99% | 1,322,381 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LRMR Stock
Select your edition
All financial news and data tailored to specific country editions
